International Stem Cell Corporation to Present Clinical Data at the Society for Neuroscience Annual Meeting
October 30, 2018 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Doses Tenth Patient in Parkinson's Disease Clinical Trial
October 08, 2018 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Raised Funds Through a Private Placement at Premium to Market
October 02, 2018 08:00 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic Program
August 21, 2018 07:00 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Aug. 21, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Announces Record Sales and Operating Results for the Three and Six-Months ended June 30, 2018
August 15, 2018 07:00 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Aug. 15, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Developed 3D Liver Structures
August 06, 2018 07:00 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Expands Manufacturing Capabilities for Biomedical Products
July 10, 2018 07:00 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing...
International Stem Cell Corporation Publishes Advanced Stem Cell Therapy Methodology in Stem Cells and Development Journal
June 25, 2018 07:00 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Doses First Patient of the Third Cohort in Parkinson's Disease Clinical Trial
June 11, 2018 07:00 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation to Launch Advanced Joint Supplement
June 05, 2018 07:00 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...